Paget's disease of the breast differential diagnosis: Difference between revisions
Preeti Singh (talk | contribs) No edit summary |
Preeti Singh (talk | contribs) No edit summary |
||
Line 27: | Line 27: | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations | ! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations | ||
! | ! rowspan="2" |Para-clinical findings | ||
| rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold Standard | | rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold Standard | ||
| rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Associated factors''' | | rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Associated factors''' | ||
Line 34: | Line 34: | ||
! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
|- | |- | ||
Line 45: | Line 44: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Breast Exam | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Breast Exam | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
|- | |- | ||
! rowspan="20" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin disorders | ! rowspan="20" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin disorders | ||
Line 52: | Line 50: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |Ulcerated, crusted, or scaling lesion on the nipple that extends to the areolar region | | align="center" style="background:#F5F5F5;" |Ulcerated, crusted, or scaling lesion on the nipple that extends to the areolar region | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 67: | Line 64: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Extramammary Paget's disease]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Extramammary Paget's disease]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 111: | Line 107: | ||
* White dermographism | * White dermographism | ||
* Perifollicular accentuation | * Perifollicular accentuation | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Epidermal psoriasiform [[hyperplasia]] | * Epidermal psoriasiform [[hyperplasia]] | ||
Line 142: | Line 137: | ||
* Localized [[swelling]] | * Localized [[swelling]] | ||
* [[Lichenification|Lichenified]] [[Itch|pruritic]] [[plaques]] | * [[Lichenification|Lichenified]] [[Itch|pruritic]] [[plaques]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Eosinophilic]] spongiosis and [[microvesicles]] | * [[Eosinophilic]] spongiosis and [[microvesicles]] | ||
Line 170: | Line 164: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Auspitz's sign]] (pinpoint bleeding) | * [[Auspitz's sign]] (pinpoint bleeding) | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Epidermal]] [[hyperplasia]] | * [[Epidermal]] [[hyperplasia]] | ||
Line 209: | Line 202: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* All [[UV radiation]]<nowiki/>or sun exposed areas can be effected independently | * All [[UV radiation]]<nowiki/>or sun exposed areas can be effected independently | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 247: | Line 239: | ||
* White to yellowish surface scales | * White to yellowish surface scales | ||
* Red-yellowish background | * Red-yellowish background | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Keratinocytic dysplasia of the epidermis | * Keratinocytic dysplasia of the epidermis | ||
Line 277: | Line 268: | ||
* Shiny white to red, translucent or opaque structureless areas | * Shiny white to red, translucent or opaque structureless areas | ||
* Multiple small erosions | * Multiple small erosions | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Large, hyperchromatic, oval nuclei | * Large, hyperchromatic, oval nuclei | ||
Line 287: | Line 277: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Intraductal papilloma|Benign intraductal papilloma]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Intraductal papilloma|Benign intraductal papilloma]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 303: | Line 292: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Pagetoid dyskeratosis | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Pagetoid dyskeratosis | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 330: | Line 318: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |[[Ultrasound]]: | | align="center" style="background:#F5F5F5;" |[[Ultrasound]]: | ||
Line 338: | Line 325: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Nipple duct adenoma | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Nipple duct adenoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 354: | Line 340: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign Toker cell hyperplasia | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign Toker cell hyperplasia | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 381: | Line 366: | ||
* Localized [[inflammation]] of [[breast]] | * Localized [[inflammation]] of [[breast]] | ||
* [[Tenderness]] | * [[Tenderness]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 390: | Line 374: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mondors disease]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mondors disease]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 419: | Line 402: | ||
* [[Breast]][[tenderness]] | * [[Breast]][[tenderness]] | ||
* Swollen [[breast]][[tissue]] | * Swollen [[breast]][[tissue]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 433: | Line 415: | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Inflammatory Breast Cancer | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Inflammatory Breast Cancer | ||
| align="center" style="background:#F5F5F5;" |[[Malignant]] | | align="center" style="background:#F5F5F5;" |[[Malignant]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | |
Revision as of 22:03, 22 February 2019
Paget's disease of the breast Microchapters |
Differentiating Paget's disease of the breast from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Paget's disease of the breast differential diagnosis On the Web |
American Roentgen Ray Society Images of Paget's disease of the breast differential diagnosis |
Paget's disease of the breast differential diagnosis in the news |
Blogs on Paget's disease of the breast differential diagnosis |
Directions to Hospitals Treating Paget's disease of the breast |
Risk calculators and risk factors for Paget's disease of the breast differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Paget's disease of the breast must be differentiated from atopic dermatitis, eczema, psoriasis, malignant melanoma, Bowen's disease, basal cell carcinoma, and pagetoid dyskeratosis.[1][2]
Differential Diagnosis
Paget’s disease of the breast must be differentiated from other benign and malignant processes of nipple-areola complex such as:[1][2]
- Atopic dermatitis
- Chronic contact dermatitis
- Lactiferous duct ectasia
- Chronic eczema
- Psoriasis
- Nipple duct adenoma
- Malignant melanoma
- Bowen’s disease
- Superficial basal cell carcinoma
- Benign intraductal papilloma
- Pagetoid dyskeratosis
Paget's disease of the breast is often misdiagnosed as nipple eczema
Category | Diseases | Benign or Malignant | Etiology | Clinical manifestations | Para-clinical findings | Gold Standard | Associated factors | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||
Histopathology | ||||||||||||||
Rash | Nipple Discharge | Erythema | Involved areas | Mastalgia | Breast Exam | Other | ||||||||
Skin disorders | Paget's disease of the breast | Ulcerated, crusted, or scaling lesion on the nipple that extends to the areolar region |
|
|||||||||||
Extramammary Paget's disease | ||||||||||||||
Atopic dermatitis
(Eczema) |
Benign |
|
– | – | + |
|
– |
|
|
| ||||
Allergic contact dermatitis[3] | Benign |
|
Erythematous well-demarcated papules | – | – | + | Surrounding the area in contact with the offending agent | + |
|
|
| |||
Psoriasis | Benign |
|
Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales | – | + | + |
|
+ |
|
|
Risk factors include
| |||
Malignant melanoma | Malignant |
|
|
–
Bleeding from the lesion may be present |
|
| ||||||||
Bowen’s disease | Benign can turn malignant |
|
– |
|
|
|
| |||||||
Superficial basal cell carcinoma | Malignant |
|
– |
|
|
|
| |||||||
Benign intraductal papilloma | ||||||||||||||
Pagetoid dyskeratosis | ||||||||||||||
Lactiferous duct ectasia | Benign | * Common among perimenopausalwomen
|
Ultrasound:
|
|||||||||||
Nipple duct adenoma | ||||||||||||||
Benign Toker cell hyperplasia | ||||||||||||||
Breast abscess | Benign | + |
|
|
||||||||||
Mondors disease | ||||||||||||||
Mastitis |
|
+ | ± |
|
|
|||||||||
Inflammatory Breast Cancer | Malignant |
References
- ↑ 1.0 1.1 Gaspari, Eleonora; Ricci, Aurora; Liberto, Valeria; Scarano, Angela Lia; Fornari, Maria; Simonetti, Giovanni (2013). "An Unusual Case of Mammary Paget's Disease Diagnosed Using Dynamic Contrast-Enhanced MRI". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/206235. ISSN 2090-6862.
- ↑ 2.0 2.1 Lopes Filho, Lauro Lourival; Lopes, Ione Maria Ribeiro Soares; Lopes, Lauro Rodolpho Soares; Enokihara, Milvia M. S. S.; Michalany, Alexandre Osores; Matsunaga, Nobuo (2015). "Mammary and extramammary Paget's disease". Anais Brasileiros de Dermatologia. 90 (2): 225–231. doi:10.1590/abd1806-4841.20153189. ISSN 1806-4841.
- ↑ Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.